MARKET

SWAV

SWAV

SHOCKWAVE MEDICAL, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

177.70
-0.28
-0.16%
Closed 19:46 07/29 EDT
OPEN
177.99
PREV CLOSE
177.98
HIGH
181.97
LOW
175.71
VOLUME
211.75K
TURNOVER
--
52 WEEK HIGH
203.74
52 WEEK LOW
46.94
MARKET CAP
6.22B
P/E (TTM)
-85.3588
1D
5D
1M
3M
1Y
5Y
Shockwave Medical to Present at the Canaccord Genuity 41st Annual Growth Conference
SANTA CLARA, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it will be participating ...
GlobeNewswire · 1d ago
Cape Cod Five Cents Savings Bank Buys Raytheon Technologies Corp, PowerShares QQQ Trust Ser 1, ...
GuruFocus News · 1d ago
Is ShockWave Medical, Inc. (SWAV) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and no...
Insider Monkey · 2d ago
SVB Leerink Starts ShockWave Medical at Outperform with $208 Price Target
MT Newswires · 07/16 10:33
Shockwave Medical to Report Second Quarter 2021 Financial Results on August 9, 2021
SANTA CLARA, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will ...
GlobeNewswire · 07/15 20:05
SVB Leerink Believes ShockWave Is Well-Positioned In Calcified Cardiovascular Market
Benzinga · 07/15 14:35
What 9 Analyst Ratings Have To Say About ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago
Benzinga · 07/12 15:09
B of A Securities Downgrades ShockWave Medical to Neutral, Raises Price Target to $200
B of A Securities analyst Bob Hopkins downgrades ShockWave Medical (NASDAQ:SWAV) from Buy to Neutral and raises the price target from $180 to $200.
Benzinga · 07/12 11:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SWAV. Analyze the recent business situations of SHOCKWAVE MEDICAL, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SWAV stock price target is 193.00 with a high estimate of 208.00 and a low estimate of 152.00.
EPS
Institutional Holdings
Institutions: 260
Institutional Holdings: 33.29M
% Owned: 95.15%
Shares Outstanding: 34.98M
TypeInstitutionsShares
Increased
70
3.82M
New
32
510.54K
Decreased
76
3.47M
Sold Out
40
385.35K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.52%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Non-Executive Chairman/Independent Director
C. Raymond Larkin
President/Chief Executive Officer/Director
Douglas Godshall
Chief Financial Officer
Daniel Puckett
Other
Isaac Zacharias
Independent Director
Laura Francis
Independent Director
Frederic Moll
Independent Director
Maria Sainz
Independent Director
F. Thomas Watkins
No Data
About SWAV
Shockwave Medical, Inc. is a medical device company. The Company is engaged in the development of Intravascular Lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Its products for the treatment of Peripheral Artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of Coronary Artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.

Webull offers kinds of Shockwave Medical Inc stock information, including NASDAQ:SWAV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SWAV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SWAV stock methods without spending real money on the virtual paper trading platform.